Today: 25 April 2026
Subscribe

GSK stock price ends week higher as Feb 4 earnings loom — what investors watch next

GSK stock price ends week higher as Feb 4 earnings loom — what investors watch next

GSK shares rose 1.3% to 1,876.5 pence in London on Friday, extending a two-day rally ahead of fourth-quarter results due Feb. 4. Investors are watching for 2026 guidance and updates on vaccine and specialty drug demand. The stock remains about 9% below its December high. GSK recently agreed to buy RAPT Therapeutics for $2.2 billion and signaled changes in its HIV joint venture.
31 January 2026
··
Shell share price in focus as buyback wraps and oil jumps ahead of earnings

Shell share price in focus as buyback wraps and oil jumps ahead of earnings

Shell shares closed Friday at 2,794 pence, down 0.1%, as the company ended its latest buyback program and announced new repurchases. Brent crude surged to near $72 a barrel, its highest since August, ahead of Sunday’s OPEC+ meeting. Shell bought back over 1.36 million shares this week for cancellation. The company will report Q4 earnings on Feb. 5.
31 January 2026
···
Glencore stock heads into a big week as Rio Tinto deadline nears and copper cools

Glencore stock heads into a big week as Rio Tinto deadline nears and copper cools

Glencore shares fell 1.7% to 499.25 pence Friday after metals prices dropped and copper retreated from record highs. Investors await a possible Rio Tinto bid by Feb. 5 and watch for further takeover-code disclosures. Glencore’s 2025 copper output dropped 11% to 851,600 tonnes, but second-half production rebounded. Geode Capital disclosed a 0.93% Glencore stake in new filings.
31 January 2026
··
Lloyds share price hits fresh 52-week high as buyback starts — what to watch next week

Lloyds share price hits fresh 52-week high as buyback starts — what to watch next week

Lloyds Banking Group shares closed Friday at 108.95 pence, up 3.32% to a 52-week high, after launching a £1.75 billion buyback and raising its 2026 profitability target. The bank reported a 12% rise in 2025 pre-tax profit to £6.7 billion. Lloyds bought 10 million shares Friday for cancellation. Investors await the Bank of England’s rate decision Feb. 5 and Lloyds’ annual report Feb. 18.
31 January 2026
·
RELX share price ends week near 52-week low as buyback rolls on — what to watch next

RELX share price ends week near 52-week low as buyback rolls on — what to watch next

RELX shares fell 0.6% to 2,579 pence in London Friday, remaining near a 52-week low despite the company’s ongoing buyback program. RELX purchased 369,515 shares at an average 2,594.5 pence as part of a £250 million repurchase running through Feb. 6. Investors await full-year results due Feb. 12. The stock dropped 3.6% Thursday, underperforming the FTSE 100.
31 January 2026
··
Genting Singapore share price (SGX:G13) in focus after Lim Kok Thay takes Resorts World Sentosa chair

Genting Singapore share price (SGX:G13) in focus after Lim Kok Thay takes Resorts World Sentosa chair

Genting Singapore shares closed at S$0.735 on Friday, up 0.68%, after Lim Kok Thay was named chairman and director of Resorts World at Sentosa, effective Feb. 1. The stock traded 32.8 million shares between S$0.730 and S$0.740. Analysts flagged ongoing competition with Marina Bay Sands and weak tourism growth as risks. Full-year 2025 results are due Feb. 24 after market close.
31 January 2026
·
Sembcorp Industries stock: after the Alinta vote, what investors watch next

Sembcorp Industries stock: after the Alinta vote, what investors watch next

Sembcorp Industries shares fell 1.6% to S$6.03 Friday after shareholders approved the A$6.5 billion acquisition of Australia’s Alinta Energy, with 99.76% voting in favor. The cash deal will be funded by a fully committed bridge loan, with no equity raise planned. Singapore’s Straits Times Index closed down 0.5%. Sembcorp expects to close the Alinta deal in the first half of 2026, pending regulatory approval.
31 January 2026
1 … 361 362 363 364 365 … 1,866

Stock Market Today

  • TSX Stock Poised for 22% Upside as Alternative Energy Gains Amid U.S.-Israel-Iran Conflict
    April 24, 2026, 6:03 PM EDT. David Rosenberg of Rosenberg Research highlights a rebound in alternative energy stocks due to the U.S.-Israel-Iran tensions. The conflict reinforces energy security as a crucial priority, easing negative sentiment around clean energy. Investors are advised to manage geopolitical risks within portfolios rather than making hasty trades. Opportunities span beyond energy generation to batteries, grid modernization, and energy storage. Commodities linked to renewables include copper, uranium, lithium, nickel, and rare earth metals. Rosenberg recommends ETFs such as IBAT, ICLN, COPX, BASE, CPCC, REMX, and URA for exposure. The iShares Global Clean Energy ETF (ICLN) has surged nearly 10% since the conflict began. These developments present renewable energy not only as a growth area but also as a diversifier and hedge for investors.

Latest article

Magnachip Semiconductor Stock Jumps 23% as New BatteryFET Puts Q1 Earnings in Focus

Magnachip Semiconductor Stock Jumps 23% as New BatteryFET Puts Q1 Earnings in Focus

24 April 2026
Magnachip Semiconductor’s U.S.-listed shares jumped 23% late Friday to $5.25 ahead of its April 28 earnings report. The company this week launched two 8th-generation 12V MOSFETs for smartphone battery protection, with one already in mass production for a major global smartphone maker. Magnachip has guided for Q1 revenue of $44–$48 million and a gross margin of 14–16%. Analysts expect a loss of 22 cents per share.
HCA Healthcare Stock Drops Despite Profit Beat As Weak Volumes Rattle Investors

HCA Healthcare Stock Drops Despite Profit Beat As Weak Volumes Rattle Investors

24 April 2026
HCA Healthcare shares dropped 8.8% to $432.46 after first-quarter profit narrowly beat estimates but showed weaker patient volumes and payer-mix concerns. Revenue rose 4.3% to $19.1 billion, net income hit $1.62 billion, and adjusted EBITDA climbed 1.9% to $3.8 billion. Respiratory admissions fell 42% year-over-year. HCA reaffirmed its 2026 financial guidance.
Go toTop